Stryker and OrthoSensor extended their agreement to co-market Stryker's Triathlon knee system and OrthoSensor's Verasense feedback instrument for knee-replacement surgery.
Stryker ticked its overall revenue up about 1.2% last quarter, but the costs of all-metal hip recalls and FDA ire erased that growth, dragging the company's net profit down 13.1% compared to the previous year.
Stryker has recalled its ShapeMatch Cutting Guides over manufacturing concerns, and now the FDA has assigned a Class I tag to the effort, warning that the devices could lead to serious injury or death.
The FDA is warning of additional death and injury reports related to Stryker's Neptune waste management systems, devices the company sold without agency clearance.
Stryker is buying up a number of VertiFlex's spinal surgery implants and technologies for an undisclosed price.
The FDA hit Stryker with a warning letter for failing to disclose a recall and selling devices without agency clearance.
Stryker has wrapped up its $764 million acquisition of Trauson Holdings, giving it a major foothold in China's orthopedics device industry.
For 2012, the top 10 medical device and med tech companies didn't produce soaring gains, revenue-wise. Rather, their revenue increases generally took the slow and steady path. There are...
An Iowa woman is suing Stryker for safety problems over Stryker's now-recalled Rejuvenate metal-on-metal hip implant.
A federal jury has ordered Zimmer to make a $70 million payout to Stryker, determining "willful infringement" involving three different patents.